Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Klaus Lücke"'
Autor:
Paul Friedrich Geus, Felix Hehnen, Sophia Krakowski, Klaus Lücke, Dave S. B. Hoon, Nikolaj Frost, Ulrich Kertzscher, Gabi Wendt
Publikováno v:
Cancers, Vol 14, Iss 19, p 4753 (2022)
Circulating tumor cells (CTCs) exist in low quantities in the bloodstream in the early stages of cancers. It, therefore, remains a technical challenge to isolate them in large enough quantities for a precise diagnosis and downstream analysis. We intr
Externí odkaz:
https://doaj.org/article/fbce8a231d9945709c39f3256c6c76a1
Autor:
Gerit Theil, Kersten Fischer, Ekkehard Weber, Rita Medek, Raschid Hoda, Klaus Lücke, Paolo Fornara
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0158354 (2016)
Circulating tumor cells (CTCs) constitute a useful approach for personalized medicine. Nevertheless, the isolation of these cells remains very challenging because they rarely circulate in the blood. Another current problem is the cancer-specific char
Externí odkaz:
https://doaj.org/article/6282c694a5dc4a63acb94e76df3f50f0
Autor:
Klaus Pantel, Thomas Krahn, Christian Schumann, Oliver von Ahsen, Nora Brychta, Stephen Jackson, Harriet Wikman, Klaus Lücke, Johannes Tucholski, Sabine Riethdorf, Simon A. Joosse, Thomas Schalk, Nicole Penkalla, Tobias M. Gorges
Purpose: The use of circulating tumor cells (CTC) as “liquid biopsy” is limited by the very low yield of CTCs available for subsequent analyses. Most in vitro approaches rely on small sample volumes (5–10 mL).Experimental Design: Here, we used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc1e62a439d0b145178028853bc432be
https://doi.org/10.1158/1078-0432.c.6523296.v1
https://doi.org/10.1158/1078-0432.c.6523296.v1
Autor:
Klaus Pantel, Thomas Krahn, Christian Schumann, Oliver von Ahsen, Nora Brychta, Stephen Jackson, Harriet Wikman, Klaus Lücke, Johannes Tucholski, Sabine Riethdorf, Simon A. Joosse, Thomas Schalk, Nicole Penkalla, Tobias M. Gorges
Supplementary Table 1. Additional table showing summarized patient data correlated to the appearance of CTCs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4528b98b1219d7176d190855d8bc12f0
https://doi.org/10.1158/1078-0432.22456395.v1
https://doi.org/10.1158/1078-0432.22456395.v1
Autor:
Wendt, Paul Friedrich Geus, Felix Hehnen, Sophia Krakowski, Klaus Lücke, Dave S. B. Hoon, Nikolaj Frost, Ulrich Kertzscher, Gabi
Publikováno v:
Cancers; Volume 14; Issue 19; Pages: 4753
Circulating tumor cells (CTCs) exist in low quantities in the bloodstream in the early stages of cancers. It, therefore, remains a technical challenge to isolate them in large enough quantities for a precise diagnosis and downstream analysis. We intr
Autor:
Paul Friedrich, Geus, Felix, Hehnen, Sophia, Krakowski, Klaus, Lücke, Dave S B, Hoon, Nikolaj, Frost, Ulrich, Kertzscher, Gabi, Wendt
Simple Summary: Detection of circulating tumor cells (CTCs) in blood can be used to diagnose cancer or monitor treatment response for various cancers. However, these cells are rare in the bloodstream in the early stages of cancers, and it, therefore,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be7b1db1008840c3b52100d3283c0a9f
Autor:
Ulrich Hasse, Andreas Bollmann, Heike Kahlert, Klaus Lücke, Katja Vahl, Fritz Scholz, Robert Smail Jack, Tyll Utesch
Publikováno v:
Gold Bulletin. 52:99-103
Metallic gold is not completely inert towards biological tissues and cells. Cytotoxicity and immunotoxicity are concerns in various gold applications. This study shows that treating the surface of gold with OH• radicals renders the gold surface non
Autor:
Klaus Lücke, Jürgen Rühe, Frank D. Scherag, Solveigh Krusekopf, Thomas Brandstetter, Robert Niestroj-Pahl
Publikováno v:
Analytical chemistry. 89(3)
The detection of circulating tumor cells (CTCs) in the blood of cancer patients is a challenging task. CTCs are, especially at the early stages of cancer development, extremely rare cells hidden in a vast background of regular blood cells. We describ
Publikováno v:
Sensors and Actuators B: Chemical. 165:1-6
A nanostructured chip surface was fabricated enabling binding via spaced antibodies specifically targeting surface proteins of cancer cells and detection of extremely low numbers of circulating tumor cells (CTC) without labeling using a sam ® 5 bios
Autor:
Klaus Lücke, Oliver von Ahsen, Klaus Pantel, Tobias M. Gorges, Johannes Tucholski, Sabine Riethdorf, Christian Schumann, Thomas Schalk, Thomas Krahn, Nora Brychta, Stephen M. Jackson, Nicole Penkalla, Harriet Wikman, Simon A. Joosse
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 22(9)
Purpose: The use of circulating tumor cells (CTC) as “liquid biopsy” is limited by the very low yield of CTCs available for subsequent analyses. Most in vitro approaches rely on small sample volumes (5–10 mL). Experimental Design: Here, we used